Hyderabad:“Not reading Dasarathi's writings does not harm him, but it greatly harms today’s poets, writers, and youth, as ...

Ladies and gentlemen, good day, and welcome to the Quarter Two FY 2025 Earnings Conference Call of Dr. Reddy's Laboratories Limited. As a reminder, all participants' lines will be in the listen-only ...

Journey Medical's new rosacea treatment will rival industry giant Galderma's Oracea in the treatment of rosacea.

Dr. Reddy’s Laboratories consolidated net profit declined 9.5% for the September quarter to ₹1,341.9 crore compared to ₹1,482.2 crore in the year earlier period even as the generic drugmaker reported ...

Dr. Reddy's Labs is experiencing a detrimental effect on their Q2 results and profits due to the high tax rate. The decrease in volumes has specifically impacted sequential sales in the US, resulting ...

With Novo Nordisk’s patent on semaglutide set to expire in India, Dr Reddy’s is among the forerunners trying to bring the ...

Republican Dr Prasanth Reddy, is running for the House of Representatives from the third Congressional District of Kansas ...

By Rishika Sadam and Kashish Tandon HYDERABAD/BENGALURU (Reuters) -Indian generic drugmaker Dr Reddy's Laboratories' second-quarter profit was hit by one-time charges related to its joint venture with ...

Much like the trend in the domestic pharma industry, Dr Reddy's Laboratories is investing heavily in research and development aimed at ramping up the biosimilars, generics, and biologics segments. In ...

Hyderabad-based Dr Reddy's Laboratories (DRL) posted a 9.5 per cent year-on-year (Y-o-Y) decline in its consolidated profit ...

Dr. Guru N. Reddy, a renowned gastroenterologist and the Founder & Chairman of Continental Hospitals, stated, “At Continental Hospitals, we are incredibly proud to receive JCI accreditation for the ...

Dr. G. Vivekananda, a 2014 UPSC achiever and Assistant Director at the Ministry of Defense, addressed an audience of over 300 ...